| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 84.62M | 83.26M | 84.84M | 90.54M | 85.63M |
| Gross Profit | 79.15M | 83.26M | 85.30M | 86.93M | 85.63M |
| EBITDA | 64.10M | 60.95M | 66.29M | 66.01M | 66.84M |
| Net Income | 52.23M | 45.76M | 50.30M | 50.96M | 52.52M |
Balance Sheet | |||||
| Total Assets | 953.54M | 953.73M | 930.74M | 943.94M | 905.46M |
| Cash, Cash Equivalents and Short-Term Investments | 416.50M | 181.82M | 52.32M | 51.16M | 83.81M |
| Total Debt | 1.77M | 3.59M | 6.63M | 47.60M | 43.95M |
| Total Liabilities | 8.43M | 12.85M | 15.62M | 58.72M | 50.00M |
| Stockholders Equity | 945.12M | 940.88M | 915.12M | 885.22M | 855.46M |
Cash Flow | |||||
| Free Cash Flow | 286.15M | 150.62M | 66.99M | -32.33M | 16.11M |
| Operating Cash Flow | 286.20M | 152.25M | 82.04M | -32.23M | 16.46M |
| Investing Cash Flow | -15.86M | 570.00K | -13.50M | -79.00K | -348.00K |
| Financing Cash Flow | -50.43M | -23.32M | -67.38M | 1.14M | -66.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$440.00M | 6.89 | 5.52% | 5.43% | -8.15% | 14.16% | |
76 Outperform | HK$700.40M | 2.73 | 6.16% | 5.46% | 32.46% | 9.09% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$395.30M | 6.16 | 2.91% | 4.88% | -7.97% | 53.91% | |
52 Neutral | HK$994.29M | -4.65 | -8.70% | ― | 0.02% | -121.26% | |
47 Neutral | HK$573.60M | -1.95 | -12.57% | 9.77% | 9.41% | -219.96% |